BlackRock Health Sciences Opportunities Portfolio Institutional Shares (SHSSX)

Fund Assets	6.26B
Expense Ratio	0.866%
Min. Investment	$2,000,000
Turnover	49.00%
Dividend (ttm)	0.28
Dividend Yield	0.39%
Dividend Growth	11.23%
Payout Frequency	Semi-Annual
Ex-Dividend Date	Jul 22, 2026

Previous Close	71.17
YTD Return	10.90%
1-Year Return	20.89%
5-Year Return	39.85%
52-Week Low	65.37
52-Week High	76.03
Beta (5Y)	0.51
Holdings	142
Inception Date	Oct 16, 2000

About SHSSX

This portfolio primarily directs its capital, dedicating a minimum of 80% of its total assets, towards equity holdings—chiefly common shares—of companies operating within the health sciences and closely related sectors. This comprehensive category includes businesses involved in medical equipment and supplies, healthcare service provision, biotechnology, and pharmaceutical research and manufacturing. The fund maintains a focused investment approach, ensuring that more than a quarter (over 25%) of its assets are committed to these health sciences industries. Additionally, it has the flexibility to include investments in companies based outside of the United States.

• Fund Family: BlackRock
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Below Average
• Stock Exchange: Nasdaq
• Ticker Symbol: SHSSX
• Share Class: Institutional
• Index: Russell 3000 Healthcare TR

Performance

SHSSX had a total return of 20.89% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.29%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
SHSAX	Investor A	1.11%
SHISX	Service	1.16%
SHSCX	Investor C	1.90%

Top 10 Holdings

53.34% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	11.92%
Johnson & Johnson	JNJ	8.03%
Merck & Co., Inc.	MRK	5.56%
AbbVie Inc.	ABBV	5.07%
Thermo Fisher Scientific Inc.	TMO	4.41%
UnitedHealth Group Incorporated	UNH	4.33%
Gilead Sciences, Inc.	GILD	4.09%
Amgen Inc.	AMGN	3.98%
Vertex Pharmaceuticals Incorporated	VRTX	3.33%
Abbott Laboratories	ABT	2.61%

Dividend History

Ex-Dividend	Amount	Pay Date
Jul 22, 2026	$6.46449	Jul 23, 2026
Dec 9, 2025	$3.13642	Dec 10, 2025
Jul 17, 2025	$3.83665	Jul 18, 2025
Dec 11, 2024	$3.34446	Dec 12, 2024
Jul 18, 2024	$2.49135	Jul 19, 2024
Dec 7, 2023	$1.33043	Dec 8, 2023

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 15, 2026

Data Sources Report a data error